ONE Bio Corp.
ONBI
$0.003
-$0.002-40.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Revenue | 13.54M | 13.34M | 12.08M | 14.95M | 13.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.54M | 13.34M | 12.08M | 14.95M | 13.50M |
| Cost of Revenue | 7.78M | 7.27M | 6.31M | 8.88M | 8.48M |
| Gross Profit | 5.76M | 6.07M | 5.77M | 6.07M | 5.02M |
| SG&A Expenses | 1.86M | 2.06M | 1.91M | 1.90M | 1.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.73M | 9.40M | 8.36M | 10.85M | 10.37M |
| Operating Income | 3.81M | 3.94M | 3.73M | 4.10M | 3.13M |
| Income Before Tax | 2.51M | 3.56M | 3.45M | 3.77M | 2.73M |
| Income Tax Expenses | 734.80K | 1.08M | 1.02M | 1.07M | 710.50K |
| Earnings from Continuing Operations | 1.78M | 2.47M | 2.43M | 2.70M | 2.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.10K | -39.10K | -34.60K | 76.80K | -112.10K |
| Net Income | 1.75M | 2.44M | 2.40M | 2.78M | 1.91M |
| EBIT | 3.81M | 3.94M | 3.73M | 4.10M | 3.13M |
| EBITDA | 4.08M | 4.16M | 3.94M | 4.26M | 3.26M |
| EPS Basic | 0.23 | 0.35 | 0.36 | 0.46 | 0.31 |
| Normalized Basic EPS | 0.26 | 0.32 | 0.32 | 0.40 | 0.26 |
| EPS Diluted | 0.22 | 0.33 | 0.34 | 0.43 | 0.29 |
| Normalized Diluted EPS | 0.25 | 0.29 | 0.30 | 0.38 | 0.24 |
| Average Basic Shares Outstanding | 7.64M | 6.93M | 6.72M | 6.06M | 6.16M |
| Average Diluted Shares Outstanding | 8.11M | 7.46M | 7.15M | 6.42M | 6.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.22% | -- | -- | -- | -- |